Diane Godin-Ribuot

Diane Godin-Ribuot

Auto-generated profile, based on publicly available information

Diane Godin-Ribuot

Grenoble Alpes University, HP2 Laboratory, INSERM U1042, Grenoble, France

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2015 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
ABAnne Briançon-Marjollet
Anne Briançon-Marjollet
MWMartin Weiszenstein
Martin Weiszenstein
MHMarion Henri
Marion Henri
ATAmandine Thomas
Amandine Thomas
DGDiane Godin-Ribuot
Diane Godin-Ribuot
JPJan Polak
Jan Polak
Modern lifestyle has profoundly modified human sleep habits. Sleep duration has shortened over recent decades from 8 to 6.5 hours resulting in chronic sleep deprivation. Additionally, irregular sleep, shift work and travelling across time zones lead to disruption of circadian rhythms and asynchrony between the master hypothalamic clock and pacemakers in peripheral tissues. Furthermore, obstructive sleep apnea syndrome (OSA), which affects 4 - 15% of the population, is not only characterized by impaired sleep architecture but also by repetitive hemoglobin desaturations during sleep. Epidemiological studies have identified impaired sleep as an independent risk factor for all cause of-, as well as for cardiovascular, mortality/morbidity. More recently, sleep abnormalities were causally linked to impairments in glucose homeostasis, metabolic syndrome and Type 2 Diabetes Mellitus (T2DM). This review summarized current knowledge on the metabolic alterations associated with the most prevalent sleep disturbances, i.e. short sleep duration, shift work and OSA. We have focused on various endocrine and molecular mechanisms underlying the associations between inadequate sleep quality, quantity and timing with impaired glucose tolerance, insulin resistance and pancreatic β-cell dysfunction. Of these mechanisms, the role of the hypothalamic-pituitary-adrenal axis, circadian pacemakers in peripheral tissues, adipose tissue metabolism, sympathetic nervous system activation, oxidative stress and whole-body inflammation are discussed. Additionally, the impact of intermittent hypoxia and sleep fragmentation (key components of OSA) on intracellular signaling and metabolism in muscle, liver, fat and pancreas are also examined. In summary, this review provides endocrine and molecular explanations for the associations between common sleep disturbances and the pathogenesis of T2DM.

30 September 2008 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
PLPatrick LEVY
Patrick LEVY
JPJean-Louis Pepin
Jean-Louis Pepin
Claire ArnaudClaire Arnaud
Claire Arnaud
RTRenaud Tamisier
Renaud Tamisier
JBJ-C. Borel
J-C. Borel
CRC. Ribuot
C. Ribuot
There are three major types of sleep-disordered breathing (SDB) with respect to prevalence and health consequences,i.e.obstructive sleep apnoea syndrome (OSAS), Cheyne–Stokes respiration and central sleep apnoea (CSR-CSA) in chronic heart failure, and obesity hypoventilation syndrome (OHS). In all three conditions, hypoxia appears to affect body functioning in different ways. Most of the molecular and cellular mechanisms that occur in response to SDB-related hypoxia remain unknown.In OSAS, an inflammatory cascade mainly dependent upon intermittent hypoxia has been described. There is a strong interaction between haemodynamic and inflammatory changes in promoting vascular remodelling. Moreover, during OSAS, most organ, tissue or functional impairment is related to the severity of nocturnal hypoxia. CSR-CSA occurring during heart failure is primarily a consequence of cardiac impairment. CSR-CSA has deleterious consequences for cardiac prognosis and mortality since it favours sympathetic activation, ventricular ectopy and atrial fibrillation. Although correction of CSR-CSA seems to be critical, there is a need to establish therapy guidelines in large randomised controlled trials.Finally, OHS is a growing health concern, owing to the worldwide obesity epidemic and OHS morbidities. The pathophysiology of OHS remains largely unknown. However, resistance to leptin, obesity and severe nocturnal hypoxia lead to insulin resistance and endothelial dysfunction. In addition, several adipokines may be triggered by hypoxia and explain, at least in part, OHS morbidity and mortality.Overall, chronic intermittent hypoxia appears to have specific genomic effects that differ notably from continuous hypoxia. Further research is required to fully elucidate the molecular and cellular mechanisms.

1 April 2009 in JACC
Verified
Journal Article
Closed access
EBElise Belaidi
Elise Belaidi
MJMarie Joyeux-Faure
Marie Joyeux-Faure
CRChristophe Ribuot
Christophe Ribuot
SLSandrine H. Launois
Sandrine H. Launois
PLPatrick LEVY
Patrick LEVY
DGDiane Godin-Ribuot
Diane Godin-Ribuot

1 January 2009 in ILAR Journal
Verified
Journal Article
Open access
PDF file
MDMaurice Dematteis
Maurice Dematteis
DGDiane Godin-Ribuot
Diane Godin-Ribuot
Claire ArnaudClaire Arnaud
Claire Arnaud
CRChristophe Ribuot
Christophe Ribuot
FSFrançoise Stanke-Labesque
Françoise Stanke-Labesque
PLPatrick LEVY
Patrick LEVY
Sleep-disordered breathing, and particularly the highly prevalent obstructive sleep apnea syndrome, is a multicomponent disorder combining intermittent hypoxia (IH), sleep fragmentation, and obstructed respiratory efforts. It is frequently associated with comorbidities and leads to numerous complications, including cardiovascular consequences that are conditioned by genetic predisposition and environment. The complexity of the disease and the reduced possibilities for patient investigations, especially at the tissue level, have limited progress in the understanding of sleep apnea pathophysiology and in the development of specific treatments. Animal models make it possible to study the causative mechanisms (essentially upper airway dysfunction) and the consequences (cardiovascular, metabolic, and neurological alterations) of nocturnal respiratory events without the confounding factors that occur in humans. Such studies have revealed some of the pathophysiological mechanisms and enabled the recognition of IH as the most important sleep apnea component underlying cardiovascular complications. We review different animal models used to assess detrimental sleep apnea–related cardiovascular consequences: blood pressure elevation, impaired vasoreactivity, structural arterial remodeling leading to atherosclerosis, cardiac remodeling, and myocardial infarction. We also review experimental evidence of beneficial effects of IH. By combining clinical and experimental research, these models will contribute to the understanding of differential patient susceptibility and to the elaboration of prevention strategies and tailored treatments for sleep apnea patients.

22 June 2015 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
SVSamuel Verges
Samuel Verges
SCSamarmar Chacaroun
Samarmar Chacaroun
DGDiane Godin-Ribuot
Diane Godin-Ribuot
SBSébastien Baillieul
Sébastien Baillieul
Preconditioning refers to a procedure by which a single noxious stimulus below the threshold of damage is applied to the tissue in order to increase resistance to the same or even different noxious stimuli given above the threshold of damage. Hypoxic preconditioning relies on complex and active defenses that organisms have developed to counter the adverse consequences of oxygen deprivation. The protection it confers against ischemic attack for instance as well as the underlying biological mechanisms have been extensively investigated in animal models. Based on these data, hypoxic conditioning (consisting in recurrent exposure to hypoxia) has been suggested a potential non-pharmacological therapeutic intervention to enhance some physiological functions in individuals in whom acute or chronic pathological events are anticipated or existing. In addition to healthy subjects, some benefits have been reported in patients with cardiovascular and pulmonary diseases as well as in overweight and obese individuals. Hypoxic conditioning consisting in sessions of intermittent exposure to moderate hypoxia repeated over several weeks may induce hematological, vascular, metabolic and neurological effects. This review addresses the existing evidence regarding the use of hypoxic conditioning as a potential therapeutic modality and emphasizes on many remaining issues to clarify and future researches to be performed in the field.

7 December 2011 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
ARAmandine Ramond
Amandine Ramond
DGDiane Godin‐Ribuot
Diane Godin‐Ribuot
CRChristophe Ribuot
Christophe Ribuot
PTPerle Totoson
Perle Totoson
IKIrina Koritchneva
Irina Koritchneva
MJMarie Joyeux‐Faure
Marie Joyeux‐Faure